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Xanthomas of the skin are dramatic lesions and have long been noted and studied by
physicians. Until the last quarter century, however, little differentiation of the various
types and the accompanying systemic defects was made. Since then, various investigators
have clarified the problem, but at the same time have led into perplexing fields of lipid
metabolism, reticulo-endothelial disease and genetics (1, 2).
The prime differentiation is made on clinical, pathological and chemical evidence sepa-
rating the "primary" diseases of the reticulo-endothelial system from the group of xantho-
mas where an error in lipid metabolism is most likely primary. In Table I is given the work-
ing classification used in this study. The first group, primary reticulo-endothelial disease
with xanthomas, includes Letterer-Siwe disease, Hand-SchUller-Christian disease, cosine-
philic granuloma of bone, xanthoma disseminata, and nevoxantho-endothelioma. Evidence
is accumulating that the above syndromes are but variations of the same disease process.
The second group, the lipidoses associated with xanthoma, exhibits some defect in fat
metabolism which is reflected in the lipids of the serum. This group is best separated into
primary and secondary forms.
The primary form, or primary familial lipidoses, shows xanthomas of plane and tuberous
type, characteristically on the knees, buttocks, elbows, palms, soles and digits. Other ex-
ternal manifestations are tendon sheath xanthoma. Frequently, or perhaps inevitably,
severe cardiovascular disease will be associated. Any of the above manifestations may
exist simultaneously or separately, and extensive genetic studies indicate that this syn-
drome is merely the extreme manifestation of a much more wide-spread inherited defect.
The secondary lipidoses includes xanthomas of plane, tuberous or eruptive type, occa-
sionally seen in various types of liver disease, diabetes, chronic pancreatitis and myxedema.
The inclusion of the syndrome of idiopathic hyperlipemia with hepato-splenomegaly in
this group may be faulty, but suffices for the present study. A third large group is made up
of miscellaneous conditions showing foam cells in cutaneous lesions but are not "true xan-
thomas" and are not listed in the table.
The present study was carried out on the sera of 14 patients exhibiting xan-
thoma tuberosum et planum of skin and/or tendon sheath xanthoma. There
was no evidence of other diseases known to cause xanthoma, except possibly in
cases 3, 4, 5 and 7, in which the basal metabolic rate was below the normal range.
These are considered examples of primary familial lipidoses with xanthoma.
(See Table II.) In addition, the blood of 5 cases with xanthomas secondary to
primary biliary cirrhosis and 3 cases of primary reticulo-endothelial disease with
xanthoma was studied. A study of patients with xanthelasma has been made by
N. Epstein, et al. (3).
Intensive investigations of the blood lipids in xanthomatous diseases have
been made but primarily of the various chemical fractions with relatively little
attention to the lipoprotein molecules which contain most of the blood lipids.
Recently studies of the lipoproteins of the blood by the analytic ultracentrifuge
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have pointed to a new approach to the elucidation of the xanthomatous diseases
(4, 5, 6, 7, 8).
The ultracentrifugal technic allows the identification and quantitative meas-
urement of various types of lipoprotein molecules to be made. Under the influence
of the great centrifugal force developed molecules migrate at measurable rates,
and the boundaries made between the solution containing these molecules and
the solution from which they have migrated are observed. The lipoprotein mole-
cules, being less dense than the solution* in which they are suspended, actually
migrate opposite to the direction of the centrifugal force (or undergo flotation).
TABLE I
Xanthomas
I. Primary reticulo-endothelial disease with xanthoma.
A. Letterer-Siwe disease
B. Hand-Schüller-Christiari disease
C. Eosinophilic granuloma
D. Xanthoma disseminata
E. Nevoxantho-endothelioma (juvenile xanthoma)
(All of the above are probably variants of the same disease process.)
II. Lipidoses associated with xanthoma.
A. Primary familial lipidoses
I. Xanthoma of tuberous or plane type
2. Xanthoma of tendon sheaths
3. Familial nature with high incidence of cardiovascular disease and hypercho-
lesteremia in family members
4. High incidence of cardiovascular disease of atherosclerotic type.
5. Xanthelasma?
(The above may exist singly or in any combination.)
B. Secondary lipidoses with xanthoma.
1. Primarly biliary cirrhosis
2. Obstructive biliary disease (common duct, stone, etc.)
3. Chronic pancreatitis
4. Diabetes
5. Myxedema
6. Idiopathic hyperlipemia with hepato-splenomegaly. (The position of this syn-
drome is unsettled.)
The customary unit of migration rate is the Svedbergf named in honor of The
Svedberg who invented the ultracentrifuge and developed the theory of its use.
A molecule which undergoes sedimentation at a rate of 5 x 1O13 cm/sec/unit
field of force is said to have an S value of 5 or to be a molecule of the S-5 class.
When the molecule is of low enough density to undergo flotation, the same unit
can be used but then, is said to have an Si value of 5, or is a molecule of the Sf
class (f is flotation). By a detailed optical system photographs are made during
* The density of the serum is brought up to 1.063 gms/cc by addition of NaCI, exclusive
of the density contribution of the serum proteins and lipoproteins.
f One Svedberg unit equals 1 X lO' cm/sec/dyne/gm.
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TABLE II
A. Primary familial lipidoses with xanthoma
AGE CORONARY2 PERIPH- XAN- DIABETES,FAMILY1 IAND DURATION HISTORY ARTERY ERAL THOSSA TENDON SHEATH THYROID LIVER SI TOTAL
SEX DISEASE ARTERIO- TUBER- XANTHOMA 10-20 CHOL.FUNCT. ETC.SCLEROSIS OSIJM
sng.% mg.%
1 63F 10 yrs. * — ++ ++ + — 1200 596
2 52F 2 yrs. + +++ — ++ — — 520 544
3 44F 9 mo. — — — ++ — BMR —20 476 470
4 44F 1 yr. ? + — . ++ — BMR —27 385 436
5 55M 6 yrs. — ++ +++ ++ — BMR —17 298 323
6 48M 6 yrs. * ++ — ++ — — 258 592
7 33M 7 yrs. ? — + ++ — BMR —20 251 502
8 58F 5 yrs. ? + — + — — 201 460
9 47F 3 yrs. * + — ++ — — 198 640
10 14F 8 yrs. * + — + + — 119 500
11 52F 25 yrs. ? + — I — + — 103 695
12 33M 22 yrs. + — — * + — 109 436
13 26F 2 yrs. +I — — — + — 76 275
14 28F ? — —
— + (previous — 46 436
history)
1 + Family history of xanthoma
* Family history of cardiovascular dis.
Not known
2 + Angina pectoris
++ Myocardial infarcts
+++ Death from myocardial infarct.
B. Primary biliary cirrhosis
AGE AND DURATION DURATION OF TYPE OF XANTHOMA
la
2a
3a
4a
5a
27M 3 yrs. 2 yrs. Eruptive xanthoma
S1F 1 yrs. 18 mo. Plane xanthoma of crease of hands and severe
xanthelasma
58F 7 yrs. 6 yrs. Plane xanthoma of crease of hands and severe
xanthelasma
50F 1 yrs. 6 mo. Plane xanthoma of crease of hands and severe
xanthelasma
Diagnosis only — Clinical history not known.
C. Primary reticulo-endothelial disease with xanthoma
AGE AND SEX DIAGNOSIS
lb 6 mo. M Letterer-Siwe disease with multiple xanthoma
2b 28 yrs. M Xanthoma disseminata
3b 4 yrs. M Nevoxantho-endothelioma
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the ultracentrifugal runs which show the type and amount of the various lipo-
protein molecules as identified by these migration rates in terms of Sf units.
Figure 1 shows a diagram of the ultracentrifuge cell with a molecular species
undergoing flotation, a schematic diagram of the pattern obtained, and the actual
photographs of two species observed with the aid of this optical system. The
photographs are taken at successive intervals of time after the rotor has reached
full speed and the migration or flotation rate in terms of Sf units can be deter-
mined by the rate of movement of each peak as compared with the grid shown
at the top of the photographs. From the area above each peak (shaded in the
figure) one can determine the concentration of any molecular species in the
solution.
FJG. 1
THE ULTRACENTRIFUGAL COMPOSITION OF HUMAN SERUM LIPIDS
AND LIPOPROTEINS
The study by the ultracentrifugal technic of serum from thousands of pre-
sumably normal subjects from infancy to old age has revealed certain basic fea-
tures of the mechanism of lipid and cholesterol transport via lipoproteins. This
is best described in terms of the various lipoproteins of differing S values that
are found in the serum.
In the low density group of lipoprotein molecules, there exist the following
species: Sf 2, S1 4, Sf 6, Sf 8, S1 13, S1 17, S 17—20, S1 20—40, S1 40—100, S1 100
40,000. Up to S 17, discrete molecular species are found. Above S 17 there is
either a continuum of molecules or molecules so closely spaced in S rate that in-
dividual species are not readily differentiated.
Every human studied shows molecules of the group Si 6 or lower at appreciable
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concentration. In fact, it appears that this is the "normal" pattern, (as evidenced
in children and young adults especially, with a smaller proportion of older adults
showing this pattern). A progressive "defect" in lipoprotein transport has
emerged which is shown in the appearance of successively higher members of the
lipoprotein molecules in appreciable concentration in addition to those of the
S 6 and lower group. This defect is manifested at least up to Sf 40. From S 40—
40,000 the lipoproteins, in many individuals at least, represent part of alimentary
lipemia, whereas the species below S 35 are not appreciably influenced by post-
prandial hyperlipemia.
The "minor defect" is represented by the appearance of S 8 molecules in addi-
tion to those of S1 6 and lower. The successively more severe defects are best
described in the following table:
TABLE JJJ*
LIPOPROTEIN TRANSPORT AS A MEASURE OF LIPID METABOLIC DEFECT
(HUMAN)
"Normal" Pattern
(1) Lipoproteins of S1 4 and/or S 6 present at low or moderate concentrations. Minimal
levels of higher Sf components except foi transient elevations in S 30—40,000 follow-
ing fatty meals.
"Minimal" Defect
(2) Lipoproteins of S 4 and/or S 6 at increased concentrations but without any increase
in higher Sf components as compared with (1).
"Minor" Defect
(3) Lipoproteins of Sf 4 and/or Sf 6 plus Sf 8 in increasing concentration.
Progressively "More Severe" Defect
(4) S4 + 516 + 518 + SdO
(5) Sf4 + Sf6 + Sf8 + SflO + Sf13
(6) Sf4 + Sf6 + Sf8 + Sf10 + Sf13 + Sf17
(7) Sf4 + Sf6 + SfS + S110 + Sf13 + Sf17 + S17—20
(8) Sf4 + Sf6 + Sf8 + SilO + Sf13 + Sf17 + S,17--20 + Sf20—40
(9) Sf4 + Sf6 + SfS + Sl0 + Sf13 + Sf17 + S117—20 + S120—40 + Sf40—40,000
(In this group the S 40—40,000 can be of transient existence following meals or may
be sustained even post-absorptively.)
(10) "Most Severe" Defect
As in (9) except that the Sf 4 and Sf 6 may be depressed to quite low concentrations.
(This may be regarded as a general shift toward higher Sf lipoproteins, and is compa-
rable to that which appears in the rabbits in the later phases of cholesterol—Wesson
oil feeding.)
* Reprinted with permission of the publishers, from the American Journal of Medicine, vol. 11, no. 3, September
1951, pages 358-380.
It would appear that in some way the presence of molecules of S 8 and higher
in appreciable concentration reflect a "spill-over" occurring when the individual
is incapable of handling lipid transport wholly in the lower S classes. This hy-
pothesis is strengthened by the observation that before Sf 8 and higher species
appear, the level of the Sf 6 and lower molecules are usually increased. Thus, in
general, high concentrations of Sf 8 and higher species on to the Si 20-40 group
are present only when the lower species of S1 6 and below are increased. The range
of levels of Sf 6 and lower species seen before serious spill-over occurs is highly
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variable from individual to individual. However, in individuals manifesting the
most severe defect with very high S1 8—40, the Si 6 and lower species may be
actually depressed below normal. One wonders if in these cases the defect is so
severe as to preclude formation of appreciable concentration of the more "nor-
mal" S1 6 and lower molecules.
As to chemical structure, studies (9) have shown that all molecules from
S1 2-40,000 have cholesterol, phospholipids and protein. Only those above S1 17
however, contain glyceryl esters (fat). In fact, the molecules between S1 17—100
represent the maj or fat-bearers of the serum.
FIG. 2
LIPOPROTEIN PATTERN OF XANTHOMAS
Primary Familial Lipidoses with Xanthoma:
The pattern as seen in the primary xanthoma group has shown a severe defect
in lipoprotein transport and is fairly distinctive. In Figure 2 (cases 2, 5, 9, 13)
are the patterns obtained in four of this group with a normal figure for compari-
son. Cases 2 and 5 which are characteristic for the majority of the patients
studied, show a tremendous increase in concentration of the S1 10_20* molecules,
with the molecules above S1 40 and below S1 10 at relatively normal concentra-
* Actual measurements exclude Sf 10 itself and are hence between the limits of S1 12—20.
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tion. However, the concentration of the S1 40—100 Species was variable and, in
some cases, showed a moderate increase, not influenced in relation to meals.
While the molecules of the S 6 and lower class were present in normal or slightly
depressed concentration in the sera of patients with the greatest defects, some of
the patients exhibiting a less severe spill-over (as evidenced by the concentration
of the S1 10—20 and S1 20—40 groups) showed a much increased concentration of
the lower S1 classes. This is shown by Fig. 2, Cases 9 & 13, where the concentra-
tion of the S 8 and above is much lower than those in Figures 2b and 2c, but
show a marked increase in the molecules of St 8 and less. In fact, the patterns can
be looked on as exhibiting a progressively more severe defect from below upward
in Figure 2. The less "severe" cases show an increase in the S 6 and S1 8 groups
plus an elevation of the S1 10—20 and S1 20—40 groups. In the most "extreme"
patterns there is a depression of the S 6 and lower species accompanying the
great increase in S 10—20 and 20—40 molecules. It is of interest that in these cases
this parallels their clinical condition, both with respect to their xanthomas and
cardiovascular complications. Case 13 (fig. 2) has no evident cardiovascular dis-
ease and has no xanthoma at present (history of previous small tendon sheath
xanthoma—proved by pathology). Case 9 (fig. 2) is a fourteen-year-old girl with
moderate xanthoma tuberosum and tendon sheath xanthoma with angina pec-
tons. Case 9 (fig. 2) is from a man with extreme xanthoma tuberosum who has
bilateral leg amputation for arteriosclerotic obliterative vascular disease and has
had one severe myocardial infarction. Case 2 (fig. 2) is that of a patient with
severe and extensive xanthoma, studied after two myocardial infarcts and who
died from a third acute myocardial infarction. While this direct a correlation
cannot always be made, there seems to be a definite parallelism between the
severity of the lipoprotein "defect" and the severity of the clinical condition in
most cases.
PRIMARY RETICTJLO-ENDOTHELIAL DISEASE WITH XANTHOMA
In the small group of cases studied there was no significant defect in lipopro-
tein transport found as yet and the patterns corresponded to the normals.
PRIMARY BILIARY CIRRHOSIS WITH XANTHOMA
This small group of patients presented a very unique and interesting pattern
quite different from the primary xanthoma group. Here, the "defect" in carrying
cholesterol, etc., in the blood lay in a huge increase in the S1 6 and S1 8 groups
with varying increase in the Sf 10 to St 17 species, but with a rather sharp cutting
off at this point. This is well illustrated in Figure 3, which shows a sharp cut off
above Sf 13. A direct comparison of the molecules in the Sf 6 and S1 8 classes with
those of S 6 and Sf 8 classes in other sera may not be valid as there is some evi-
dence that these molecules, although having the same flotation rate, may be of
different structural and chemical composition. This is being clarified at present
by chemical analysis. Detailed lipoprotein studies of patients with biliary cirrho-
sis are in progress (10).
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COMPARISON OF CONCENTRATION OF Sf 10—20 SPECIES IN XANTHOMAS
WITH .NORMALS AND OTHER DISEASES
In Figure 4 the concentration of Sf 10—20 molecules is shown for the various
groups studied and compared with the normal range and mean values for some
FIG. 3
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other disease showing defects in lipoprotein transport. As can be seen the pri-
mary xanthoma tuberosum group shows fantastic levels of these lipoproteins in
comparison with any other group.* Of interest is that the four lowest levels in
this group are in patients with tendon sheath xanthoma alone. The primary
reticulo-endothelial diseases with xanthoma showed normal levels.
In biliary cirrhosis, in spite of enormous increases in serum cholesterol, there
was no consistent elevation of the concentration of the molecules of the S1 10—20
class, although there was always striking increase of the lipoproteins of Sf 10 and
less. Further even, in those cases where there was an elevation of the S1 10—20
class, the elevation was almost wholly in the lower members of this class as dis-
cussed previously. There is a striking contrast with the biliary cirrhosis with
xanthoma and the primary xanthomas in that the former group shows practi-
cally no lipoproteins above S 17 and higher, whereas the latter invariably
showed increases in the S1 20—40 as well as the increase in the concentration of
the Sf 10—20 class.
Recent work by Gofman et al (15) has shown that the S120—40 and S14O—100
classes of lipoproteins are strongly associated with human atherosclerosis, as
had been previously shown for the S110—20 class. The xanthomas associated
with lipidosis may be segregated as follows with respect to the various lipopro-
tein classes:
(a) Xanthomas of the tendon sheaths: Marked elevation of St3, Sf8, and
SflO—2O. Sf20—4O and Sf40—100 are normal or lower than normal.
(b) Xanthomas of the plane or tuberous type: Sf6 and S18 may be low, nor-
mal, or slightly elevated. S110—20 is markedly elevated. Sf20—40 is markedly
elevated. S40—lOO may or may not be markedly elevated.
(c) Xanthomas associated with diabetes mellitus, chronic pancreatitis, or
idiopathic hyperlipemia: S16 and Sf8 usually low or normal. S110—20 may be low,
normal, or moderately elevated. S120—40 and S140—100 are very markedly ele-
vated.
(d) Combination of (a) and (b), with both types of lesions: Marked elevation
of Sf6, Sf8, and S 10—20. Marked elevation of Sf2O—4O, with or without elevation
of S140—100.
ASSOCIATION OF CARDIOVASCULAR DISEASE AND PRIMARY XANTHOMA
The relation of cardiovascular disease due to atherosclerosis and xanthoma
tuberosum has attracted a great deal of attention recently. All of the autopsies
reported in patients fitting into the group of essential familial lipidoses with
xanthoma (essential hypercholesteremic xanthomatosis) have shown extensive
atherosclerosis of the aorta, coronary and/or peripheral vessels. The clinical evi-
dence is great on this association with many case reports of the association of
coronary artery disease and obliterative arteriosclerosis of the peripheral vessels
in the essential xanthoma group. In Montgomery's (11) series of 26 patients with
xanthoma tuberosum (some of these may have had liver disease), 13 had cardio-
* Nephrotics represent the only group thus far studied that approaches the mean average
of the xanthoma.
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vascular disease, and in MUller's (12) series, 19 out of 23 patients with xanthorna
tuberosum of the primary type had coronary artery disease as well as the occur-
rence of heart disease in 68 of 76 examined members of these patients' families.
This latter aspect of the hereditary nature of the defect of which xanthomas
tuberosum et planum and tendon sheath xanthoma are the extreme manifesta-
tions, and its relation to hypercholesteremia and cardiovascular disease in the
normal members of the family has been studied extensively in the last few years
(13, 14). In the present group, 10 out of the 14 cases studied had marked evidence
of cardiovascular disease as shown in Table II.
As noted previously, there was a fairly distinct correlation between the severity
of the defect in lipoprotein transport and the development of clinical cardiovas-
cular disease of the atherosclerotic type. This is shown both in comparative levels
of the Sc 10—20 group alone and by Figure 2 showing the total patterns. Previous
work has incriminated the Sf 10-20 and S 20—40 groups as being related or
associated with the development of atherosclerosis, both experimentally in rab-
bits and in a large series of "normal" individuals, and ones with diseases caused
by or associated with atherosclerosis (4, 5, 6, 7, 8). The present work seems to
add to this evidence, as the maj or defect again lies in the Sf 10—20 group and
is correlated with clinical evidence of atherosclerosis. (The arguments as to
whether the arterial lesions in these cases are xanthomas or atheromas are still
debated, but the majority of workers in the field consider them the same.)
COMPARISON OF S 10—20 MOLECULES WITH SERUM CHOLESTEROL
While all the cases of primary xanthoma tuberosum and primary biliary cir-
rhosis studied here have shown serum cholesterols above normal, there has been
no appreciable correlation between the concentration of the sc 10—20 molecules
and the serum cholesterol levels. If one looks at Figure 2, this is well illustrated
by comparing Case No. 5 and Case No. 13. The serum cholesterol for Case 5 is
323 mg% and the concentration of S 10—20 molecules is 298 mg%, whereas, in
Case 13 the serum cholesterol is 436, but the concentration of Sc 10—20 molecules
is only 46 mg%, but the concentration of molecules of Sf 8 and less is much in-
creased. Hence, it is obvious that there can be a wide variation in patterns with
any given cholesterol value depending on the species of molecule that is increased
in concentration. Previous studies have shown this to be true in most series
studied whether "normal" or diseased. While there is a tendency towards higher
values of Sc 10—20 molecules with increase in serum cholesterol, the presence or
concentration of these molecules or of "defect" in lipid transport cannot be
predicted from the analytic serum cholesterol levels.
While no definite statements can be made concerning the effects of various
modes of treatment on these patients, the low fat, low cholesterol diet at this time
seems to be the most valuable.
SUMMARY
1. A new approach to the study of diseases exhibiting xanthomas is by ultra-
centrifugal analysis of the serum lipoproteins which transport almost all of the
serum lipids.
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2. A classification of diseases with xanthomas is presented (Table I).
3. Fourteen patients with primary familial lipidoses with xanthoma tubero-
sum et planum and/or tendon sheath xanthoma, 5 patients with xanthoma sec-
ondary to primary biliary cirrhosis, and 3 patients with primary reticulo endothe-
hal disease with xanthomas have been studied and pertinent clinical data tabu-
lated (Table II).
4. The ultracentrifugal composition of human serum lipids and lipoproteins
is characterized and an explanation of a defect in serum lipid transport which
can be of varying severity is explained (Table III).
5. The lipoproteins in sera of patients with primary familial lipidoses with
xanthoma tuberosum exhibit a defect in lipid transport which is of varying
severity, but as a group these patients show the most severe defect of any group
studied with the possible exception of nephrotics.
6. The "defect" in the lipoprotein pattern in patients with "primary" xan-
thoma tuberosum is reflected in variable concentrations of the S1 8 and lower
molecular classes of lipoproteins, but shows extreme increases in the concentra-
tion of the S1 10—20 and S1 20—40 classes of lipoproteins. The patients showing the
least severe "defect" have much increased concentrations of the Sf 8 and lower
species but with a less severe "spill-over" of the S1 10—20 and S1 20—40 group,
whereas, this was reversed in the patients with the more severe defects with the
concentration of the Sf 10—40 lipoprotein molecules being tremendously increased
with a normal or even depressed concentration of the S1 8 and lower species. It is
of interest that the clinical condition of these patients as exhibited both in the
extent of xanthomatous changes and the presence and severity of cardiovascular
disease of the atherosclerotic type is paralleled by the severity of the defect in
lipid transport.
7. In the small group of reticulo-endothelial disease with xanthomas studied,
no appreciable defect was noted.
8. The pattern exhibited by the primary biliary cirrhosis group with xanthoma
was unique and consistent. The defect in lipid transport here was shown in an
extreme increased concentration of the Sf 8 and lower species with variable in-
creased concentrations in the species up to Sf 17 class but with a rather sharp
cutting off at this point.
9. The association of atherosclerotic cardiovascular disease with primary
xanthoma tuberosum is noted and the significance of this in regard to the lipopro-
teins in the serum in this series seems to incriminate the S1 10—20 and S1 20—40
classes which is in agreement with previously studied "normal" groups and dis-
eases associated with or caused by atherosclerosis.
10. A comparison of the lipoproteins of the serum with serum cholesterol has
shown no direct correlation in levels of serum cholesterol and the severity of the
defect in lipid transport.
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